Business FDA Lifts Clinical Hold on Neurizon’s NUZ-001 for ALS Trials The U.S. Food and Drug Administration (FDA) has lifted the clinical hold on Neurizon Therapeutics Limited’s investigational therapy, NUZ-001, a significant step forward for... Editorial4 hours ago